Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Buy
+689
New +$143K ﹤0.01% 2356
2025
Q2
– Sell
-300
Closed -$71.6K – 3431
2025
Q1
$67.1K Sell
300
-2,831
-90% -$661K ﹤0.01% 2657
2024
Q4
$716K Buy
+3,131
New +$754K ﹤0.01% 1978

Other funds holding RMD

PEAK6's RMD Position: Q2 2026 in Review

PEAK6 opened a new position in ResMed (RMD) in Q2 2026: 689 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #2356 among its holdings. This is a return to the name: PEAK6 previously reported a position in RMD as recently as Q1 2025.

PEAK6 first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. The position peaked at $716K in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • PEAK6 held 689 shares of ResMed worth $134K as of Q2 2026.
  • ResMed was a new PEAK6 position in Q2 2026.
  • ResMed made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2356 holding.
  • PEAK6 first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
  • PEAK6's ResMed position peaked at $716K in Q4 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.